ATMI opens US laboratory for bioprocess application support

Published: 13-Jun-2013
Manufacturing

Company brings successful lab approach from Europe to provide comprehensive solutions to North American customers at Bloomington site


ATMI, a leader in single-use bioprocess solutions, has opened a US-based laboratory for applications development and testing as part of the company’s strategy of implementing interactive, long-term customer support along with its innovative single-use disposable technologies.

Located inside its Bloomington, MN manufacturing facility, the lab will support process operations using the full ATMI LifeSciences portfolio of single-use bioprocess solutions, including bioprocess vessels, bioreactors, mixers and its fill/finish platform.

The site is a duplicate of ATMI’s original laboratory located in Brussels, Belgium. The Belgian lab was introduced in 2008 to develop and validate the Integrity iCELLis and Xpansion bioreactors. However, the scope of the lab quickly grew to include full support services for all ATMI LifeSciences technologies.

With the addition of the new 100m2, fully equipped Bloomington laboratory, ATMI has extended this depth of support to US-based customers. Together, the labs offer direct access to the expertise of 15 global application specialists and scientists that are dedicated to working on customer bioprocess development efforts.

The new Bloomington lab features development and operations support in a round-the-clock format. Customers taking advantage of the lab can benefit from the ability to align directly with application staff to develop and optimise processes, test bioprocess applications, scale-up individual cell culture processes for technical transfer, learn through demonstrations how ATMI technologies work, and receive any further training that may be needed.

‘The new location is a clear reflection of ATMI’s strategy to provide comprehensive bioprocess solutions and invest in customer support,’ said Senior Vice President and General Manager of ATMI LifeSciences, Mario Phillips. ‘The laboratory is fully equipped with ATMI technologies and equipment to perform cell culture, and it is staffed by experts in the field.

‘The team at this site has extensive experience in cell culture bioprocesses development and scale-up, as well as more than 20 protein, virus and cell production processes that have been developed in ATMI’s proprietary bioreactors. The team will be fully focused on understanding the challenges that customers are faced with and applying their technical knowledge to offer guidance.’

  • Companies:
  • ATMI LifeSciences
See more

You may also like

Manufacturing

Opinion: Moving the goal posts

Read more
Suppliers of cleanroom technologies look set to benefit from the boom in biopharmaceuticals

Trending Articles

  1. Fume hoods: A guide to testing velocity A high airflow velocity is not a guarantee of containment. Qualification expert Jesus Casas walks you through the protocols required to make sure your velocity is spot on
  2. RABS, isolators and the track-and-trace trend Traditional aseptic production lines are a thing of the past. Isolators are being integrated with traceability systems to watch over safety of the product and the staff. Jorge Nuero of Telstar explains
  3. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  4. Micronclean Micronclean’s passion is to be the first to develop new technological solutions that change the shape of the markets we serve. Micronclean has been owned and managed by one family since the 1920’s and throughout our history, we have focused on quality, innovation, attention to detail and customer care.
  5. Solo Containment adds polyurethane half-suit to portfolio Polyurethane film has excellent mechanical properties and is free of phthalate, making it suitable for contact with pharmaceutical products

Upcoming event

Pharmig Annual Pharmaceutical Microbiology Conference

20–21 November 2024 | Conference | Nottingham, UK See all

You may also like

Manufacturing

Opinion: Moving the goal posts

Suppliers of cleanroom technologies look set to benefit from the boom in biopharmaceuticals
Manufacturing

ATMI announces technology investment with Medinstill

Partnership to deliver sterile connector and fill technology
Manufacturing

ATMI and Finesse Solutions sign distribution agreement

Will allow both companies to offer seamless support for single-use bioreactor systems
Manufacturing

ATMI and Disposable-Lab introduce first single-use platform for fill/finish operations

Offers a smaller footprint and is fully disposable
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Gas storage with no added pressures

Hazardous, toxic gases used in semiconductor fabrication are stored in and delivered from high-density media that adsorb gas molecules inside nano-sized pore structures, virtually eliminating accidental gas releases. ATMI’s BrightBlack precision nanoporous carbon has been specifically optimised for pore size and density to achieve the most favourable physical adsorption of these dangerous gas molecules.
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Leak detection in process vessels

In the manufacture of biologicals single-use disposable flexible vessels are commonly used as bioreactors, mixers and sterile fill stations. To guarantee the vessels are of the quality needed to ensure process integrity, they must be proven free from biological contamination and free of leaks that could be an ingress route for contaminants such as bacteria. The traditional pressure decay method has significant limitations, so ATMI has created a reliable and repeatable method involving pressurising the vessel with helium instead of air. By using this method, defects as small as 10µm can be easily detected.
Manufacturing

ATMI announces Helium Integrity Testing

Detects leaks from holes as small as 10 microns in single-use bioprocess vessels
Subscribe now